Curaleaf Holdings (CURLF) Free Cash Flow (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Free Cash Flow of -$32.6 million for Q4 2024, up 13.96% year-over-year from -$28.6 million in Q1 2024, and down 146.52% quarter-over-quarter from $70.2 million in Q3 2024.
Curaleaf Holdings (CURLF) Free Cash Flow (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Free Cash Flow history runs 6 years deep, the most recent figure standing at -$32.6 million for Q4 2024.
- In Q4 2024, Free Cash Flow rose 13.96% year-over-year to -$32.6 million; the TTM figure through Sep 2025 stood at -$32.6 million (down 130.98% YoY), while the FY2025 annual figure was $134.9 million, down 9.09% from the prior year.
- Free Cash Flow for Q4 2024 stood at -$32.6 million, down from $70.2 million in the prior quarter.
- The five-year high for Free Cash Flow was $43.8 billion in Q1 2024, with the low at -$43.7 billion in Q2 2024.
- The 5-year median for Free Cash Flow is $22.4 million (2020), against an average of $3.0 million.
- The sharpest annual moves came in 2020 and 2023: Free Cash Flow soared 1408983.21% in 2020, then sank 21301.34% in 2023.
- Curaleaf Holdings' Free Cash Flow stood at -$177.3 million in 2020, then surged by 113.4% to $23.8 million in 2021, then tumbled by 999.0% to -$213.6 million in 2022, then jumped by 82.24% to -$37.9 million in 2023, then advanced by 13.96% to -$32.6 million in 2024.
- Business Quant data shows CURLF's Free Cash Flow at -$32.6 million in Q4 2024, $70.2 million in Q3 2024, and -$43.7 billion in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -32.64 Mn |
| Dec 31, 2024 | -32.64 Mn |
| Sep 30, 2024 | 70.16 Mn |
| Sep 30, 2024 | 70.16 Mn |
| Jun 30, 2024 | -43.70 Bn |
| Jun 30, 2024 | -43.70 Bn |
| Mar 31, 2024 | 43.78 Bn |
| Mar 31, 2024 | 43.78 Bn |
| Dec 31, 2023 | -37.94 Mn |
| Dec 31, 2023 | -37.94 Mn |
| Sep 30, 2023 | 62.18 Mn |
| Sep 30, 2023 | 62.18 Mn |
| Jun 30, 2023 | -7.88 Bn |
| Jun 30, 2023 | -7.88 Bn |
| Mar 31, 2023 | 7.90 Bn |
| Mar 31, 2023 | 7.90 Bn |
| Dec 31, 2022 | -213.59 Mn |
| Dec 31, 2022 | -213.59 Mn |
| Sep 30, 2022 | 43.98 Mn |
| Sep 30, 2022 | 43.98 Mn |